Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Alvotech (NASDAQ: ALVO) tekur þátt í árlegri heilbrigðisráðstefnu fjárfestingabankans Barclays í Miami í Flórida, sem haldin verður í 27. skipti dagana 11. – 13. mars nk. Róbert Wessman,...
-
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays 27th...
-
REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
-
Alvotech (NASDAQ: ALVO) birtir uppgjör fyrir fjórða ársfjórðung 2024 og ársuppgjör 2024 miðvikudaginn 26. mars nk. eftir lokun markaða. Uppgjörsfundur með greinendum, sem sendur er út í beinum...
-
Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that it will release financial results...
-
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of...
-
Matvæla- og lyfjastofnun Bandaríkjanna (FDA) hefur heimilað notkun Selarsdi fyrir allar sömu ábendingar og frumlyfsins StelaraFDA hefur jafnframt tilkynnt að öll lyfjaform Selarsdi verði útskiptanleg...
-
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of...
-
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines...
-
Alvotech (NASDAQ: ALVO) og samstarfsaðili þess Teva Pharmaceuticals, bandarískt dótturfélag Teva Pharmaceutical Industries Ltd. tilkynntu í dag að Matvæla- og lyfjastofnun Bandaríkjanna (FDA) hafi...